Differences in maternal gene expression in Cesarean section delivery compared with vaginal delivery.

Area of Science:

• Immunology
• Genetics
• Reproductive Medicine

Background:

• Cesarean section (CS) is an environmental risk factor for chronic immune diseases.
• Understanding maternal gene expression differences by delivery mode can elucidate CS's role in later-life disease.
• Postpartum immune system adaptation varies by delivery method.

Purpose of the Study:

• To investigate the association between delivery mode and postpartum maternal gene expression.
• To identify specific genes and pathways influenced by vaginal delivery versus Cesarean section.
• To explore potential mechanisms linking delivery mode to immune health outcomes.

Main Methods:

• Cross-sectional study of 324 mothers with full-term singleton births.
• Comparison of postpartum gene expression between vaginal delivery (n=181) and Cesarean section (n=143) groups.
• Analysis focused on antimicrobial peptides (AMPs) and related genes, including Peptidase Inhibitor 3 (PI3).

Main Results:

• Antimicrobial peptides (AMPs) were significantly upregulated in vaginal deliveries compared to Cesarean sections (with or without labor).
• Peptidase Inhibitor 3 (PI3), involved in antimicrobial and anti-inflammatory functions, showed a twofold increase in vaginal delivery.
• Statistical significance was high for PI3 upregulation in vaginal delivery (adjusted p-values < 4x10^-11).

Conclusions:

• Vaginal delivery is associated with increased expression of antimicrobial peptides postpartum.
• This upregulation may represent a protective mechanism against immune dysregulation linked to Cesarean section.
• Further research is warranted to confirm if AMP upregulation mitigates risks of CS-associated chronic immune diseases.